Artisan Partners Limited Partnership - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 195 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artisan Partners Limited Partnership ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$23,668,286
-28.4%
2,837,924
-1.4%
0.04%
-32.8%
Q4 2022$33,044,342
-1.0%
2,878,427
+8.6%
0.06%
-1.7%
Q3 2022$33,385,000
+8.2%
2,649,616
-9.2%
0.06%
+13.5%
Q2 2022$30,864,000
-33.2%
2,917,209
+2.7%
0.05%
-14.8%
Q1 2022$46,201,000
+17.4%
2,841,405
+0.0%
0.06%
+29.8%
Q4 2021$39,351,000
-4.0%
2,841,230
-0.4%
0.05%
-6.0%
Q3 2021$40,974,000
-17.6%
2,851,384
-9.3%
0.05%
-15.3%
Q2 2021$49,699,000
+61.5%
3,143,485
+3.9%
0.06%
+51.3%
Q1 2021$30,770,0003,025,6060.04%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders